Lin-CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade

Catherine T Flores1, Tyler J Wildes2, Jeffrey A Drake2

  • 1University of Florida Brain Tumor Immunotherapy Program, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, 1149S Newell Dr, L2-100, Gainesville, FL, 32611, USA. catherine.flores@neurosurgery.ufl.edu.

Nature Communications
|October 19, 2018
PubMed

Insights

Hematopoietic stem cells (HSCs) expressing C-C chemokine receptor type 2 (CCR2+) overcome resistance to immunotherapy in brain tumors. This approach sensitizes models of glioblastoma and medulloblastoma to curative treatment.

Area of Science:

  • Immunology
  • Neuro-oncology
  • Stem Cell Biology

Background:

  • Immune checkpoint blockade with anti-PD-1 antibodies shows promise for solid tumors but is ineffective against brain tumors.
  • Central nervous system (CNS) malignancies are often resistant to current immunotherapeutic strategies.

Purpose of the Study:

  • To investigate the potential of hematopoietic stem and progenitor cells (HSCs) to overcome resistance to immunotherapy in brain tumors.
  • To explore the role of C-C chemokine receptor type 2 (CCR2)-expressing HSCs in sensitizing brain tumors to PD-1 blockade and adoptive cellular therapy.

Main Methods:

  • Utilized preclinical models of glioblastoma and medulloblastoma.
  • Administered bone marrow-derived, lineage-negative HSCs expressing CCR2 (CCR2+ HSCs) in combination with PD-1 blockade.
  • Analyzed T-cell frequency, activation, and differentiation of HSCs into antigen-presenting cells within the tumor microenvironment.

Main Results:

  • CCR2+ HSC transfer reversed resistance to PD-1 blockade in CNS malignancies.
  • HSC transfer enhanced T-cell frequency and activation within intracranial tumors.
  • CCR2+ HSCs migrated to brain tumors, differentiated into antigen-presenting cells, and cross-presented tumor antigens to CD8+ T cells, sensitizing tumors to immunotherapy.

Conclusions:

  • CCR2+ HSCs represent a novel therapeutic strategy to overcome brain tumor resistance to PD-1 checkpoint blockade.
  • HSC transfer can sensitize invasive brain tumors, including glioblastoma and medulloblastoma, to both PD-1 blockade and adoptive cellular therapy.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
PD Controller: Design01:26

PD Controller: Design

In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
655